ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליה - pramipexole dihydrochloride monohydrate 1 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa.

ישראל - עברית - Ministry of Health

boehringer ingelheim israel ltd. - pramipexole dihydrochloride monohydrate - טבליה - pramipexole dihydrochloride monohydrate 0.25 mg - pramipexole - pramipexole - treatment of signs and symptoms of idiopathic parkinson's disease, as monotherapy or in combination with lovodopa. for symptomatic treatment of moderate to severe idiopathic restless legs syndrome.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 2 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 8 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

ישראל - עברית - Ministry of Health

glaxo smith kline (israel) ltd - ropinirole as hydrochloride 4 mg - film coated tablets - prolonged release - ropinirole - ropinirole is indicated for the treatment of parkinson's disease. ropinirole is effective as early therapy in patients requiring dopaminergic therapy. as adjunctive treatment to l-dopa, ropinirole enhances the efficacy of l-dopa, including control of "on-off" fluctuations and "end of dose" effects associated with chronic l-dopa therapy and permits reduction in daily l-dopa dose.

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - arginine; aspartic acid; disodium phosphate dodecahydrate; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; magnesium chloride hexahydrate; methionine; phenylalanine; potassium acetate; proline; serine; sodium acetate trihydrate; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; glycine 12.00 g/l; l- alanine 10.50 g/l; proline 5.50 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; potassium acetate 2.453 g/l; sodium acetate trihydrate 2.858 g/l; magnesium chloride hexahydrate 0.508 g/l; lysine as acetate 8.56 g/l; disodium phosphate dodecahydrate 3.581 g/l - combinations

ישראל - עברית - Ministry of Health

lapidot medical import and marketing ltd - arginine; aspartic acid; glutamine; glycine; histidine; isoleucine; l- alanine; leucine; lysine as acetate; lysine as monohydrate; methionine; phenylalanine; proline; serine; threonine; tryptophan; tyrosine; valine - תמיסה לאינפוזיה - isoleucine 5.00 g/l; leucine 8.9 g/l; methionine 4.40 g/l; phenylalanine 4.70 g/l; threonine 4.20 g/l; tryptophan 1.60 g/l; valine 6.20 g/l; arginine 11.50 g/l; histidine 3.00 g/l; l- alanine 10.50 g/l; glycine 12.00 g/l; aspartic acid 5.60 g/l; glutamine 7.20 g/l; proline 5.50 g/l; serine 2.30 g/l; tyrosine 0.40 g/l; lysine as acetate 5.74 g/l; lysine as monohydrate 3.12 g/l - combinations

ישראל - עברית - Ministry of Health

eldan electronic instruments co ltd - ioflupane - תמיסה להזרקה - ioflupane 74 mbq/ml - iodine ioflupane (123i) - other dopaminergic agents - datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain parkinsonian syndromes in order to help differentiate essential tremor from parkinsonian syndromes related to idiopathic parkinson's disease multiple system atrophy and progressive supranuclear palsy. - datscan is unable to discriminate between parkinson's disease multiple system atrophy and progressive supranuclear palsy. - to help differentiate probable dementia with lewy bodies from alzheimer's disease. datscan is unable to discriminate between dementia with lewy bodies and parkinson's disease dementia

ישראל - עברית - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

ישראל - עברית - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.